Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT05562011
Other study ID # IRB00073729
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date August 18, 2021
Est. completion date October 24, 2022

Study information

Verified date September 2023
Source Wake Forest University Health Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this research is evaluate vital signs (VS), which include non-invasive blood pressure, pulse rate, respiratory rate and Oxygen Saturation (SpO2) using a portable wrist monitoring device called a Caretaker. This device has been cleared by the Food and Drug Administration (FDA) for use and allows the study team to check vital signs in a participant's normal setting. Participation in this study will involve wearing this portable device at 2 different time points: 1. for up to 24 hours immediately during and after the participant's preoperative visit to obtain baseline vital signs during normal activity and during sleep and 2. after surgery up to 24 hours while participant recovers prior to discharge from the hospital


Description:

Anesthesiologists and surgeons examine vital signs such as heart rate (HR), respiratory rate (RR), oxygen saturation (SaO2) and blood pressure (BP) in an effort to detect extremes of altered VS and remediate these alterations prior to surgery and anesthesia. In most preoperative clinics, however, these VS are measured once and no further assessments are made until they arrive for their surgery. Patients with cardiac and pulmonary disease, however, can have highly variable VS. The Caretaker device is a wrist device designed to measure relatively continuous VS over a period up to 24 hours. The device is accompanied by a finger cuff that measure pulse and respiratory rate, along with a non-invasive blood pressure detector and pulse oximeter. In an effort to detect VS that may not be recognized with the usual one-time measurement in the clinic, the study team plans to monitor ambulatory preoperative VS in patients who meet the study criteria, for up to 16-24 hours preoperatively. They will then return their device on the day of surgery. Postoperatively, the study team will place a CareTaker device once again and measure these same VS in the same patients for up to 24 hours prior to discharge.


Recruitment information / eligibility

Status Terminated
Enrollment 61
Est. completion date October 24, 2022
Est. primary completion date September 22, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility - Inclusion Criteria - Age>18 years - Scheduled for surgery from an outpatient setting and scheduled for a pre-admission PAC appointment - Risk stratification placing them in the top 25th percentile using our internally-validated PAC Risk Score. - Exclusion Criteria - Surgery on the day of admission (same-day surgery) - Any upper extremity surgery

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Caretaker Device placement
a continuous non-invasive blood pressure and vital signs monitor that is worn on the wrist

Locations

Country Name City State
United States Wake Forest Health Sciences Winston-Salem North Carolina

Sponsors (1)

Lead Sponsor Collaborator
Wake Forest University Health Sciences

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Preoperative Caretaker Monitor Placement Success Number of participants who had the presence of (data existing for at least 70% of 5-minute time periods) for all of the vital signs of interest together--heart rate (HR), blood pressure (BP), respiratory rate (RR), arterial oxygen saturation (SaO2) after placement of the device on the subject's wrist and hand. Baseline
Primary Ease of Use Determined by Number of Participants With Sleep or Activities of Daily Living (ADLs) Interference Participants' description of ease of use (interfered with Activities of Daily Living (ADLs) or sleep) in Yes/No format. Data will be collected to demonstrate percent of patients who answered "Yes" to Sleep or ADL interference. Free text will also be recorded for qualitative purposes. Shows Caretaker Feasibility. Pre-Op Hour 24
Primary Postoperative Caretaker Healthcare Provider (HCP) Usability Using postoperative nurse verbal feedback on usability of the Caretaker monitor on subjects scheduled for surgery during the perioperative period. Percent of nurses who answer yes to the question: Did you have any difficulty using the Caretaker monitor? Post-Op Hour 24
Primary Caretaker Data Capture Rate Number of participants with no missing values expressed Pre-Op Hour 24
Primary Caretaker Data Capture Rate Number of participants with no missing values expressed Intraoperative; from the time the Operating Room monitors are placed on the patient until they come off at the end of the case, an average of 2 hours
Primary Caretaker Data Capture Rate Number of participants with no missing values expressed Post-Op Hour 24
Primary Monitor Return Rate Percent of monitors returned to our research technicians Baseline through Pre-Op Hour 24
Secondary Heart Rate Pre-Op hour 24, Post-Op Hour 24
Secondary Heart Rate--percent of Time Parameters Percentage of time heart rate is <60 bpm or >90 bpm Pre-Op Hour 24, Post-Op Hour 24
Secondary Respiratory Rate Pre-Op hour 24, Post-Op Hour 24
Secondary Respiratory Rate--Percent of Time Parameters Percent of time respirations are <8 rpm or >20 rpm Pre-Op hour 24, Post-Op Hour 24
Secondary Arterial Oxygen Saturation (SaO2) oxygen saturation level as detected by the pulse oximeter Post-Op Hour 24
Secondary SaO2--Percent of Time Percentage of time SaO2 is between 95-100% Pre-Op Hour 24, Post-Op Hour 24
Secondary Non-Invasive Systolic Blood Pressure (SBP) Pre-Op Hour 24, Post-Op Hour 24
Secondary Non-Invasive Mean Arterial Blood Pressure (MBP) Pre-Op Hour 24, Post-Op Hour 24
Secondary Non-Invasive Diastolic Blood Pressure (DBP) Pre-Op Hour 24, Post-Op Hour 24
Secondary Non-Invasive Blood Pressure--MBP Percent of Time Parameters Percent time MBP is <60 mmHg and/or >90 mmHg Pre-Op Hour 24, Post-Op Hour 24
Secondary Mortality Rate Percent declared dead Day 30
Secondary Average Length of Hospital Stay Number of days from hospital admission to discharge Up to Postoperative Day 30
Secondary ICU Transfer Rate Percent of study participants transferred to an ICU during their hospital stay Up to Postoperative Day 30
Secondary Number of Rapid Response Team Calls Number of calls made to the hospital's "Rapid Response Team" (RRT) during subjects' hospital stay. The RRT is called by nurses if the patient is experiencing stroke-like symptoms, chest pain refractory to medical treatment, or vital signs (HR, RR, BP, SaO2) meeting a pre-defined out of range value. During hospitalization up to Postoperative Day 30
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03994419 - PErioperAtive CHildhood ObesitY
Active, not recruiting NCT01681238 - Goal-directed Therapy in High-risk Surgery N/A
Recruiting NCT05613439 - The Fast-track Centre for Hip and Knee Replacement Database
Recruiting NCT03740438 - Modeling of the Hemoglobin Drop in the Uncomplicated Postoperative Course
Completed NCT03269760 - Multimodal Sleep Pathway for Shoulder Arthroplasty Phase 1
Recruiting NCT05594199 - Feasibility of a Virtual Smoking Cessation Program N/A
Completed NCT00538499 - Fentanyl With or Without Bupivacaine in Reducing Pain in Patients Undergoing Video-Assisted Chest Surgery N/A
Recruiting NCT01690338 - A Study of Residual Curarization Incidence in China Phase 4
Recruiting NCT01110798 - J-Pouch Colorectal Anastomosis or Straight Colorectal Anastomosis in Treating Patients With Rectal Cancer Who Have Undergone Surgery to Remove the Tumor N/A
Completed NCT00859157 - Pain After Tumescent Mastectomy or Standard Mastectomy in Women With Stage I, Stage II, or Stage III Breast Cancer N/A
Withdrawn NCT03531268 - Prospective Study to Evaluate the Clinical Utility of Perioperative Pharmacogenomic Testing N/A
Recruiting NCT04356638 - a Phase III Trial of Safety and Efficacy of Premedication With Dexmedetomidine and Midazolam in Pediatric Patients Phase 3
Completed NCT03579121 - Genomic Opioid Optimization of Dosing and Selections (GOODS) Study N/A
Completed NCT03899441 - Multimedia Aid Gynecologic Counseling and Consent N/A
Recruiting NCT06123039 - Use of Heart-lung Interaction to Predict Haemodynamic Tolerance to the Open Lung Approach With Individualised PEEP
Completed NCT01672892 - Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer Phase 3
Completed NCT01510652 - More Options Available With a Quadripolar LV Lead pRovidE In-clinic Solutions to CRT Challenges N/A
Completed NCT01680367 - Wound Dressings For Split-Thickness Skin Graft Donor Sites in Patients Undergoing Surgery N/A
Active, not recruiting NCT00005600 - Axillary Drainage Following Lymph Node Dissection in Women With Stage I or Stage II Breast Cancer N/A
Recruiting NCT05743673 - SHAPE Test for Preoperative Risk Stratification